Patents by Inventor Lionel Levet

Lionel Levet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEINS USED FOR THE DIAGNOSIS OF LYME BORRELIOSIS
    Publication number: 20180238874
    Abstract: Chimera proteins includlng: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii, and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii. Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.
    Type: Application
    Filed: April 19, 2018
    Publication date: August 23, 2018
    Applicant: BIOMERIEUX
    Inventors: Lionel LEVET, Odile MEJAN-LETOURNEUR
  • Proteins used for the diagnosis of lyme borreliosis
    Patent number: 9977020
    Abstract: Chimera proteins including: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii, and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii. Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: May 22, 2018
    Assignee: BIOMERIEUX
    Inventors: Lionel Levet, Odile Mejan-Letourneur
  • PROTEINS USED FOR THE DIAGNOSIS OF LYME BORRELIOSIS
    Publication number: 20170205407
    Abstract: Chimera proteins including: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii, and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii. Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.
    Type: Application
    Filed: February 9, 2016
    Publication date: July 20, 2017
    Applicant: BIOMERIEUX
    Inventors: Lionel LEVET, Odile MEJAN-LETOURNEUR
  • Proteins used for the diagnosis of lyme borreliosis
    Patent number: 9347943
    Abstract: Chimera proteins including: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii, and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii. Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.
    Type: Grant
    Filed: August 26, 2010
    Date of Patent: May 24, 2016
    Assignee: BIOMERIEUX
    Inventors: Lionel Levet, Odile Mejan-Letourneur
  • Proteins used for the diagnosis of lyme borreliosis
    Patent number: 9290548
    Abstract: A nucleic acid encoding a chimeric protein, the chimeric protein including (i) at least one amino acid sequence having at least 50% sequence identity with any of the amino acid sequences selected from the group consisting of SEQ ID NOS: 1-5, and (ii) at least one amino acid sequence having at least 80% sequence identity with any of the amino acid sequences selected from the group consisting of SEQ ID NOS: 6-8. The chimeric protein includes at least one amino acid sequence of (i) and at least one amino acid sequence of (ii) that are from different Borrelia strains or species.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: March 22, 2016
    Assignee: BIOMERIEUX
    Inventors: Lionel Levet, Odile Mejan-Letourneur
  • PROTEINS USED FOR THE DIAGNOSIS OF LYME BORRELIOSIS
    Publication number: 20150037881
    Abstract: A nucleic acid encoding a chimeric protein, the chimeric protein including (i) at least one amino acid sequence having at least 50% sequence identity with any of the amino acid sequences selected from the group consisting of SEQ ID NOS: 1-5, and (ii) at least one amino acid sequence having at least 80% sequence identity with any of the amino acid sequences selected from the group consisting of SEQ ID NOS: 6-8. The chimeric protein includes at least one amino acid sequence of (i) and at least one amino acid sequence of (ii) that are from different Borrelia strains or species.
    Type: Application
    Filed: October 15, 2014
    Publication date: February 5, 2015
    Applicant: BIOMERIEUX
    Inventors: Lionel LEVET, Odile MEJAN-LETOURNEUR
  • Proteins used for the diagnosis of lyme borreliosis
    Patent number: 8895257
    Abstract: Chimera proteins including: (i) at least one sequence of a VlsE protein of a Borrelia species selected from B. garinii, B. burgdorferi sensu stricto and B. afzelii, and (ii) at least one sequence including sequences of the IR6 domain of B. burgdorferi sensu stricto, B. afzelii and B. garinii. Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.
    Type: Grant
    Filed: August 27, 2010
    Date of Patent: November 25, 2014
    Assignee: Biomerieux
    Inventors: Lionel Levet, Odile Mejan-Letourneur
  • PROTEINS USED FOR THE DIAGNOSIS OF LYME BORRELIOSIS
    Publication number: 20120156694
    Abstract: Chimera proteins including: (i) at least one sequence of a VlsE protein of a Borrelia species selected from B. garinii, B. burgdorferi sensu stricto and B. afzelii, and (ii) at least one sequence including sequences of the IR6 domain of B. burgdorferi sensu stricto, B. afzelii and B. garinii. Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.
    Type: Application
    Filed: August 27, 2010
    Publication date: June 21, 2012
    Applicant: BIOMERIEUX
    Inventors: Lionel Levet, Odile Mejan-Letourneur
  • PROTEINS USED FOR THE DIAGNOSIS OF LYME BORRELIOSIS
    Publication number: 20120135027
    Abstract: Chimera proteins including: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii, and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii. Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.
    Type: Application
    Filed: August 26, 2010
    Publication date: May 31, 2012
    Applicant: BIOMERIEUX
    Inventors: Lionel Levet, Odile Mejan-Letourneur